Ad
related to: cancer research journal ranking- What is Immunotherapy?
Unleash the power of the immune
system to fight cancer.
- Ways to Give Back
Donate, fundraise, shop, or match.
Make a charitable bequest, registry
- Make A Sustained Impact
Donate a small amount every month
to support ongoing cancer research.
- Why Donate?
We can change the way cancer is
treated and cured. Make an impact.
- What is Immunotherapy?
Search results
Results from the WOW.Com Content Network
It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang. [1] The journal was established in 1916 as the Journal of Cancer Research, was renamed American Journal of Cancer in 1931, and obtained its current name in 1941.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics.
In Clarivate's 2021 Journal Citation Reports indexed by Web of Science, the European Journal of Cancer received an impact factor of 10.002, ranking it 21st journal out of 220 journals in the category cancer research and 26th journal out of 369 journals in the category oncology in the Scimago Journal Ranking. [1] [2]
The Nature Index is a database that tracks institutions and countries/territories and their scientific output since its introduction in November 2014. [1] Originally released with 64 natural-science journals, the Nature Index expanded to 82 natural-science journals in 2018, then added 64 health-science journals in 2023.
The SCImago Journal Rank ... originated from a research group at the University of Granada. ... Ca-A Cancer Journal for Clinicans 1 621
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.
Negative consequences of rankings are generally well-documented and relate to the performativity of using journal rankings for performance measurement purposes. [20] [21] Studies of methodological quality and reliability have found that "reliability of published research works in several fields may be decreasing with increasing journal rank", [22] contrary to widespread expectations.
Cancer Discovery has become a premier journal in the field of cancer research, with a 2020 impact factor of 39.397 that is the highest among the AACR journals. [6] [7] Research published in the journal includes identification of actionable genomic alterations in cancer, mechanisms of therapy resistance, clinical trials on targeted therapy, and ...
Ad
related to: cancer research journal ranking